# LGI Homes, Inc.: overview

LGIH · Nasdaq · CIK 1580670 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lgih.md) · [Financials](/companies/lgih/financials.md) · [Filings](/companies/lgih/filings.md) · [Insiders](/companies/lgih/insiders.md)

Latest reported revenue: [$516.0m](/filings/0001580670-26-000072.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:Revenues, accession 0001580670-26-000072).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [652](/filings/0001580670-25-000076.md) | [557 d](/filings/0001580670-26-000019.md) | [351](/filings/0001580670-26-000048.md) | [488](/filings/0001580670-26-000072.md) | [397](/filings/0001580670-25-000076.md) | [474 d](/filings/0001580670-26-000019.md) | [320](/filings/0001580670-26-000048.md) | [516](/filings/0001580670-26-000072.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.3%](/filings/0001580670-25-000076.md) | [8.2% d](/filings/0001580670-26-000019.md) | [0.0%](/filings/0001580670-26-000048.md) | [8.1%](/filings/0001580670-25-000058.md) | [5.4%](/filings/0001580670-25-000076.md) | [3.9% d](/filings/0001580670-26-000019.md) | [(0.2%)](/filings/0001580670-26-000048.md) | not reported |
| Net margin | % | [10.7%](/filings/0001580670-25-000076.md) | [9.1% d](/filings/0001580670-26-000019.md) | [1.1%](/filings/0001580670-26-000072.md) | [6.5%](/filings/0001580670-26-000072.md) | [5.0%](/filings/0001580670-25-000076.md) | [3.7% d](/filings/0001580670-26-000019.md) | [0.7%](/filings/0001580670-26-000072.md) | [5.2%](/filings/0001580670-26-000072.md) |
| Diluted EPS | $ per share | [2.95](/filings/0001580670-25-000076.md) | not reported | [0.17](/filings/0001580670-26-000048.md) | [1.36](/filings/0001580670-26-000072.md) | [0.85](/filings/0001580670-25-000076.md) | not reported | [0.09](/filings/0001580670-26-000048.md) | [1.16](/filings/0001580670-26-000072.md) |
| Free cash flow | $m | [(17.8) d](/filings/0001580670-25-000076.md) | [56.4 d](/filings/0001580670-26-000019.md) | [(128)](/filings/0001580670-26-000048.md) | [(86.4) d](/filings/0001580670-26-000072.md) | [(13.3) d](/filings/0001580670-25-000076.md) | [86.8 d](/filings/0001580670-26-000019.md) | [(56.2)](/filings/0001580670-26-000048.md) | [114 d](/filings/0001580670-26-000072.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,050](/filings/0001580670-24-000012.md) | [2,304](/filings/0001580670-25-000016.md) | [2,359](/filings/0001580670-26-000019.md) | [2,203](/filings/0001580670-26-000019.md) | [1,706](/filings/0001580670-26-000019.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [18.0%](/filings/0001580670-24-000012.md) | [16.9%](/filings/0001580670-25-000016.md) | [9.9%](/filings/0001580670-26-000019.md) | [9.6%](/filings/0001580670-26-000019.md) | [4.7%](/filings/0001580670-26-000019.md) |
| Net margin | % | [14.1%](/filings/0001580670-24-000012.md) | [14.2%](/filings/0001580670-25-000016.md) | [8.4%](/filings/0001580670-26-000019.md) | [8.9%](/filings/0001580670-26-000019.md) | [4.3%](/filings/0001580670-26-000019.md) |
| Diluted EPS | $ per share | [17.25](/filings/0001580670-24-000012.md) | [13.76](/filings/0001580670-25-000016.md) | [8.42](/filings/0001580670-26-000019.md) | [8.30](/filings/0001580670-26-000019.md) | [3.12](/filings/0001580670-26-000019.md) |
| Free cash flow | $m | not reported | [(372)](/filings/0001580670-25-000016.md) | [(58.4)](/filings/0001580670-26-000019.md) | [(146)](/filings/0001580670-26-000019.md) | [(141)](/filings/0001580670-26-000019.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lgih/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $226.8m | 3,561,545 |  | Added +125,294 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $82.4m | 1,293,672 |  | Added +18,723 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $76.9m | 1,207,427 |  | Reduced −33,327 |
| [Atlas FRM LLC](/funds/1879898.md) | 2026-06-30 | $61.6m | 967,000 |  | Added +327,000 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $56.3m | 883,343 |  | Added +14,435 |
| [DISCIPLINED GROWTH INVESTORS INC /MN](/funds/1050442.md) | 2026-06-30 | $51.9m | 815,069 |  | Added +93,468 |
| [River Road Asset Management, LLC](/funds/1341401.md) | 2026-06-30 | $50.9m | 798,542 |  | Reduced −38,865 |
| [CDAM (UK) Ltd](/funds/1719387.md) | 2026-06-30 | $46.2m | 725,470 |  | Reduced −174,761 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $46.1m | 723,490 |  | Reduced −359,304 |
| [Altshuler Shaham Ltd](/funds/1324290.md) | 2026-06-30 | $45.5m | 714,265 |  | Reduced −372,998 |

## Recent filings

[All 701 filings](/companies/lgih/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 20:23 ET | [8-K](/filings/0001580670-26-000080.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001580670-26-000080 |
| 2026-08-04 | 20:30 ET | [10-Q](/filings/0001580670-26-000072.md) | Quarterly report, period 2026-06-30 | 0001580670-26-000072 |
| 2026-08-04 | 13:00 ET | [8-K](/filings/0001580670-26-000069.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001580670-26-000069 |
| 2026-06-10 | 21:00 ET | [8-K](/filings/0001580670-26-000053.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001580670-26-000053 |
| 2026-04-28 | 20:30 ET | [10-Q](/filings/0001580670-26-000048.md) | Quarterly report, period 2026-03-31 | 0001580670-26-000048 |
| 2026-04-28 | 12:20 ET | [8-K](/filings/0001580670-26-000044.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001580670-26-000044 |
| 2026-04-27 | 15:55 ET | [8-K](/filings/0001580670-26-000039.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001580670-26-000039 |
| 2026-03-13 | 20:33 ET | [DEF 14A](/filings/0001580670-26-000030.md) | Proxy statement, period 2025-12-31 | 0001580670-26-000030 |
| 2026-02-20 | 23:35 ET | [10-K](/filings/0001580670-26-000019.md) | Annual report, period 2025-12-31 | 0001580670-26-000019 |
| 2026-02-17 | 13:19 ET | [8-K](/filings/0001580670-26-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001580670-26-000007 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001580670-26-000019.md), filed Feb 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c4bd410b-b24e-41ea-b358-83df14477b0f)

## About the filer

- CIK: 1580670
- Tickers: LGIH
- Exchange: Nasdaq
- SIC code: 1531 Operative Builders
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.